Abiopharma

🔍 Sakellaris George P (Director)

Company: Ameresco, Inc. (AMRC)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Class A Common Stock at $25.95 per share (Direct)
  Date: 2026-08-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 993,597.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,000 shares of Class A Common Stock at $25.27 per share (Direct)
  Date: 2026-08-10 | Code: P | equity_swap_involved: 0 | shares_owned_after: 994,597.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,000 shares of Class A Common Stock at $25.9 per share (Direct)
  Date: 2026-08-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 995,597.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By trust | shares_owned_after: 1,100,000.00 | Footnotes: F4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 200,000.00 | Footnotes: F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.64 to $26.20, inclusive.
• F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.22 to $25.31, inclusive.
• F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.70 to $26.00, inclusive. The reporting person undertakes to provide to Ameresco, Inc., any security holder of Ameresco, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes 1 through 3 to this Form 4.
• F4: Shares held by a trust for the benefit of the reporting person's children, who share the reporting person's household. The reporting person may be deemed the beneficial owner of the shares held by the trust. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
• F5: The reporting person disclaims beneficial ownership of the shares held by his spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of his spouse's shares for purposes of Section 16 or for any other purpose.